7th Eurasian Hematology Oncology Summit
2020 Update on MRD in AML: Does Decitabine Prolong RFS/OS in Newly Diagnosed Disease? Can Aza Help Achieve MRD Negativity? Is CC-486 Effective as Post-Remission Maintenance Therapy in Older Patients?
By
7th Eurasian Hematology Oncology Summit
FEATURING
Farhad Ravandi
By
7th Eurasian Hematology Oncology Summit
FEATURING
Farhad Ravandi
Comments 0
Login to view comments.
Click here to Login
